Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-κB, p38 and JNK
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Growing evidence suggests that alterations of the inflammatory/immune system contribute to the pathogenesis of major depression and that inflammatory processes may influence the antidepressant treatment response. Depressed patients exhibit increased levels of inflammatory markers in both the periphery and brain, and high co-morbidity exists between depression and diseases associated with inflammatory alterations. Trazodone (TDZ) is a triazolopyridine derivative that belongs to the class of serotonin receptor antagonists and reuptake inhibitors. Although the trophic and protective properties of classic antidepressants have extensively been exploited, the effects of TDZ remain to be fully elucidated. In this study, the pharmacological activities of TDZ on human neuronal-like cells were investigated under both physiological and inflammatory conditions. An in vitro inflammatory model was established using lipopolysaccharide (LPS) and tumour necrosis factor-α (TNF-α), which efficiently mimic the stress-related changes in neurotrophic and pro-inflammatory genes. Our results showed that TDZ significantly increased the mRNA expression of both brain-derived nerve factor (BDNF) and cAMP response element-binding protein (CREB) and decreased the cellular release of the pro-inflammatory cytokine interferon gamma (IFN-γ) in neuronal-like cells. In contrast, neuronal cell treatment with LPS and TNF-α decreased the expression of CREB and BDNF and increased the expression of nuclear factor kappa B (NF-κB), a primary transcription factor that functions in inflammatory response initiation. Moreover, the two agents induced the release of pro-inflammatory cytokines (i.e., interleukin-6 and IFN-γ) and decreased the production of the anti-inflammatory cytokine interleukin-10. TDZ pre-treatment completely reversed the decrease in cell viability and counteracted the decrease in BDNF and CREB expression mediated by LPS-TNF-α. In addition, the production of inflammatory mediators was inhibited, and the release of interleukin-10 was restored to control levels. Furthermore, the intracellular signalling mechanism regulating TDZ-elicited effects was specifically investigated. TDZ induced extracellular signal-regulated kinase (ERK) phosphorylation and inhibited constitutive p38 activation. Moreover, TDZ counteracted the activation of p38 and c-Jun NH2-terminal kinase (JNK) elicited by LPS-TNF-α, suggesting that the neuro-protective role of TDZ could be mediated by p38 and JNK. Overall, our results demonstrated that the protective effects of TDZ under inflammation in neuronal-like cells function by decreasing pro-inflammatory signalling and by enhancing anti-inflammatory signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
The sleep switch: hypothalamic control of sleep and wakefulness
Saper, C. B., Chou, T. C., & Scammell, T. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02002-6 · Cited by 1,656
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 1×
“LPS administration can induce depression-like behaviours in animals [52-54].”
BackgroundParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“…studies have demonstrated that selective serotonin reuptake inhibitors (SSRIs) and mood stabilizers not only decrease immunotherapy-induced depressive symptoms but also decrease the inflammatory response and lower pro-inflammatory factors (IL-2, IL-6, TNF-α, and interferon gamma (IFN-γ)) [12,13].”
BackgroundThe Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995
Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-66 · Cited by 629 · cited 1×
“Neuronal-like cell pre-treatment with TDZ for 24 or 72 h also significantly reduced the release of pro-inflammatory cytokines and counteracted the decrease in anti-inflammatory cytokines as demonstrated previously for a tricyclic anti-depressant in animal models [11,12,57,58].”
BackgroundTargeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585 · cited 4×
“In the adult mouse, inflammatory cytokines, brain injury and ischemic insult, or exposure to psychological acute stressors induces hippocampal JNK activation [9].”
BackgroundInfluentialZhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Signaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537 · cited 1×
“Moreover, some antidepressant drugs ( i.e. , escitalopram and paroxetine) promote dendritic outgrowth and increase synaptic protein levels via mTOR signalling [47,48], subsequently resulting in a rapid antidepressant-like effect in rats [49,50].”
BackgroundLicinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380 · cited 2×
“Over the last two decades, several lines of evidence have demonstrated that proinflammatory cytokines are involved in the pathophysiology of depression [2,3], suggesting that inflammatory processes may influence the antidepressant treatment response.”
BackgroundEffects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370 · cited 1×
“Neuronal-like cell pre-treatment with TDZ for 24 or 72 h also significantly reduced the release of pro-inflammatory cytokines and counteracted the decrease in anti-inflammatory cytokines as demonstrated previously for a tricyclic anti-depressant in animal models [11,12,57,58].”
BackgroundThe Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · cited 1×
“In addition, whereas the levels of -derived nerve factor (BDNF) and of the cAMP response element-binding protein (CREB) decrease in stress induced animal models of depression, their levels significantly increase after classic antidepressant treatment [10, 14-17].”
BackgroundIllness, Cytokines, and Depression
YIRMIYA, R., POLLAK, Y., MORAG, M., REICHENBERG, A., BARAK, O., AVITSUR, R., SHAVIT, Y., OVADIA, H., WEIDENFELD, J., MORAG, A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05412.x · Cited by 284
5-HT1A receptor-regulated signal transduction pathways in brain
Polter, A. M., & Li, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.019 · Cited by 225 · cited 1×
“Specifically, ERK1/2 activation and p38 pathway inhibition have been reported to involve agonistic effects at the 5HT 1A serotonin receptor [63,64], inhibition of the 5HT 2A serotonin receptor [63], and inhibition of SERT [65,66].”
BackgroundYang, C., Hu, Y.-M., Zhou, Z.-Q., Zhang, G.-F., & Yang, J.-J. (2013) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.724118 · Cited by 173 · cited 1×
“Moreover, some antidepressant drugs ( i.e. , escitalopram and paroxetine) promote dendritic outgrowth and increase synaptic protein levels via mTOR signalling [47,48], subsequently resulting in a rapid antidepressant-like effect in rats [49,50].”
BackgroundKurrasch‐Orbaugh, D. M., Parrish, J. C., Watts, V. J., & Nichols, D. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01921.x · Cited by 138 · cited 1×
“Specifically, ERK1/2 activation and p38 pathway inhibition have been reported to involve agonistic effects at the 5HT 1A serotonin receptor [63,64], inhibition of the 5HT 2A serotonin receptor [63], and inhibition of SERT [65,66].”
BackgroundSon, H., Banasr, M., Choi, M., Chae, S. Y., Licznerski, P., Lee, B., Voleti, B., Li, N., Lepack, A., Fournier, N. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201191109 · Cited by 103 · cited 2×
“A significant decrease in the expression of CREB and BDNF was also observed, which is consistent with decreases in these neurotrophic factors in stress-induced animal models of depression [10,14-16 , 56 ].”
BackgroundResultAlme, M. N., Wibrand, K., Dagestad, G., & Bramham, C. R. (2007) · Neural Plasticity · doi:10.1155/2007/26496 · Cited by 103 · cited 2×
“A significant decrease in the expression of CREB and BDNF was also observed, which is consistent with decreases in these neurotrophic factors in stress-induced animal models of depression [10,14-16,56].”
BackgroundResultXing, B., Bachstetter, A. D., & Van Eldik, L. J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-84 · Cited by 101 · cited 1×
“inhibition of serotonin 5HT2 [64], hystamin H1 [68-70] and -adrenergic receptors [71-73] has been related to the inhibition of ERK phosphorylation.”
BackgroundImipramine Induces Brain-Derived Neurotrophic Factor mRNA Expression in Cultured Astrocytes
Takano, K., Yamasaki, H., Kawabe, K., Moriyama, M., & Nakamura, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12039fp · Cited by 70 · cited 13×
“In addition, whereas the levels of -derived nerve factor (BDNF) and of the cAMP response element-binding protein (CREB) decrease in stress induced animal models of depression, their levels significantly increase after classic antidepressant treatment [10, 14-17].”
BackgroundInfluential
Cited by
Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants
Borsini, A., Alboni, S., Horowitz, M. A., Tojo, L. M., Cannazza, G., Su, K.-P., Pariante, C. M., & Zunszain, P. A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.05.006 · Cited by 126
Woo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79
Hagman, S., Mäkinen, A., Ylä-Outinen, L., Huhtala, H., Elovaara, I., & Narkilahti, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.010 · Cited by 31
Metadata
- Authors
- Daniele, S., Da Pozzo, E., Zappelli, E., & Martini, C.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 27
- Issue
- 8
- Pages
- 1609-1629
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W1971593483
- Cited by
- 56
- References
- 24
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.